Cargando…
ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
The poor prognosis and high mortality of patients with ovarian cancer result in part from their poor response to platinum-based chemotherapy. However, the precise mechanism behind cisplatin resistance is still not fully understood. In the present study, the authors explored the mechanism of resistan...
Autores principales: | Xu, Yunjie, Gao, Weinan, Zhang, Yong, Wu, Shanshan, Liu, Yanan, Deng, Xinyue, Xie, Lili, Yang, Jiayan, Yu, Huimei, Su, Jing, Sun, Liankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065457/ https://www.ncbi.nlm.nih.gov/pubmed/30015875 http://dx.doi.org/10.3892/ijo.2018.4476 |
Ejemplares similares
-
Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas
por: Jain, Harsh Vardhan, et al.
Publicado: (2014) -
ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011) -
Comparison of in vitro antileukemic activity of obatoclax and ABT-737
por: Opydo-Chanek, Małgorzata, et al.
Publicado: (2016) -
ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2017) -
Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin–NFAT pathway
por: Cippà, P E, et al.
Publicado: (2012)